Endothelial Progenitor Cells in Cardiovascular Disorders

Journal of the American College of Cardiology

Volumn 49, Issue 7, 2007, Pages 741-752

  Shantsila, Eduard ^a   Watson, Timothy ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; COMPACTIN; ERYTHROPOIETIN; EZETIMIBE; GINKGO BILOBA EXTRACT; IRBESARTAN; OLMESARTAN; PUERARIN; RAMIPRIL; RAPAMYCIN; ROSIGLITAZONE; SIMVASTATIN; VALSARTAN; VARDENAFIL;

ANEMIA; ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL FUNCTION; CLINICAL FEATURE; COMORBIDITY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HEART FAILURE; HUMAN; HYPERTENSION; LIPID METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEM CELL;

AGING; ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RISK FACTORS; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

EID: 33846969572     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.09.050     Document Type: Review

References (121)

1. Drexler H., and Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 31 (1999) 51-60
2. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J Am Soc Nephrol 15 (2004) 1983-1992
3. Caplan B.A., and Schwartz C.J. Increased endothelial cell turnover in areas of in vivo Evans blue uptake in the pig aorta. Atherosclerosis 17 (1973) 401-417
4. Dimmeler S., and Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis. J Mol Med 82 (2004) 671-677
5. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
6. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (2003) 457-463
7. Scheubel R.J., Zorn H., Rolf-Edgar S., et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Col Cardiol 42 (2003) 2073-2080
8. Edelberg J.M., Tang L., Hattori K., Lyden D., and Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 90 (2002) e89-e93
9. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
10. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
11. Aicher A., Heeschen C., Mildner-Rihm C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem cell and progenitor cells. Nat Med 9 (2003) 1370-1376
12. Assmus B., Urbich C., Aicher A., et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92 (2003) 1049-1055
13. Rivard A., Berthou-Soulie L., Principe N., et al. Age dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem 275 (2000) 29643-29647
14. Tschudi M.R., Barton M., Bersinger N.A., et al. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98 (1996) 899-905
15. Cooke J.P., and Losordo D.W. Nitric oxide and angiogenesis. Circulation 105 (2002) 2133-2135
16. Hoffmann J., Haendeler J., Aicher A., et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli. Circ Res 89 (2001) 709-715
17. Murasawa S., Llevadot J., Silver M., Isner J.M., Losordo D.W., and Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106 (2002) 1133-1139
18. Hambrecht R., Wolf A., Gielen S., et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342 (2000) 454-460
19. Belardinelli R., Paolini I., Cianci G., et al. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 37 (2001) 1891-1900
20. Hambrecht R., Fiehn E., Weigl C., et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98 (1998) 2709-2715
21. Hornig B., Maier V., and Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 93 (1996) 210-214
22. Brendle D.C., Joseph L.J., Corretti M.C., Gardner A.W., and Katzel L.I. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol 87 (2001) 324-329
23. Stewart K.J., Hiatt W.R., Regensteiner J.G., and Hirsch A.T. Exercise training for claudication. N Engl J Med 347 (2002) 1941-1951
24. Laufs U., Werner N., Link A., et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109 (2004) 220-226
25. Rehman J., Li J., Parvathaneni L., et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43 (2004) 2314-2318
26. Sandri M., Adams V., Gielen S., et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 111 (2005) 3391-3399
27. Chen J.Z., Zhang F.R., Tao Q.M., Wang X.X., and Zhu J.H. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 107 (2004) 273-280
28. Wang X., Chen J., Tao Q., Zhu J., and Shang Y. Effects of ox-LDL on number and activity of circulating endothelial progenitor cells. Drug Chem Toxicol 27 (2004) 243-255
29. Imanishi T., Hano T., Sawamura T., and Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 31 (2004) 407-413
30. Imanishi T., Hano T., Matsuo Y., and Nishio I. Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Clin Exp Pharmacol Physiol 30 (2003) 665-670
31. Pellegatta F., Bragheri M., Grigore L., et al. In vitro isolation of circulating endothelial progenitor cells is related to the high density lipoprotein plasma levels. Int J Mol Med 17 (2006) 203-208
32. Imanishi T., Hano T., and Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 23 (2005) 97-104
33. Imanishi T., Hano T., and Nishio I. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 27 (2004) 101-108
34. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49 (2001) 554-560
35. Abaci A., Oguzhan A., Kahraman S., et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99 (1999) 2239-2242
36. Loomans C.J.M., deKoening E.J.P., Staal F.J.T., et al. Endothelial progenitor cell dysfunction. A novel concept in the pathogenesis of vascular complications of type I diabetes. Diabetes 53 (2004) 195-199
37. Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
38. Pistrosch F., Herbrig K., Oelschlaegel U., et al. PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183 (2005) 163-167
39. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
40. Iba O., Matsubara H., Nozawa Y., et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106 (2002) 2019-2025
41. Krankel N., Adams V., Linke A., et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 25 (2005) 698-703
42. Kondo T., Hayashi M., Takeshita K., et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 24 (2004) 1442-1447
43. Wang X., Zhu J., Chen J., and Shang Y. Effects of nicotine on the number and activity of circulating endothelial progenitor cells. J Clin Pharmacol 44 (2004) 881-889
44. Chen J.Z., Zhu J.H., Wang X.X., et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 36 (2004) 233-239
45. Schnabel R., Blankenberg S., Lubos E., et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97 (2005) e53-e59
46. Thum T., Tsikas D., Stein S., et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46 (2005) 1693-1701
47. Heeschen C., Lehman R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
48. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
49. George J., Goldstein E., Abashidze S., et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 25 (2004) 1003-1008
50. Verma S., Kukiszewski M.A., Li S.-H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function. Circulation 109 (2004) r91-r100
51. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
52. Thum T., Fraccarollo D., Galuppo P., et al. Bone marrow molecular alterations after myocardial infarction: impact on endothelial progenitor cells. Cardiovasc Res 70 (2006) 50-60
53. Wang Y., Johnsen H.E., Mortensen S., et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92 (2006) 768-774
54. Mouquet F., Pfister O., Jain M., et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res 97 (2005) 1090-1092
55. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
56. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
57. + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004) 1209-1212
58. Foresta C., Caretta N., Lana A., Cabrelle A., Palu G., and Ferlin A. Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 17 (2005) 288-290
59. George J., Herz I., Goldstein E., et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23 (2003) e57-e60
60. Simper D., Wang S., Deb A., et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of non cardiac origin are enriched in transplant atherosclerosis. Circulation 107 (2003) 143-149
61. Taguchi A., Matsuyama T., Moriwaki H., et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 109 (2004) 2972-2975
62. Ghani U., Shuaib A., Salam A., et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 36 (2005) 151-153
63. Grundy S.M. Statin trials and goals of cholesterol-lowering therapy. Circulation 97 (1998) 1436-1439
64. Maron D.J., Fazio S., and Linton M.F. Current perspectives on statins. Circulation 101 (2000) 207-213
65. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108 (2001) 399-405
66. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
67. Asahara T., Takahashi T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
68. Kalka C., Masuda H., Takahashi T., et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 (2000) 1198-1202
69. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization. A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
70. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
71. Spyridopoulos I., Haendeler J., Urbich C., et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 110 (2004) 3136-3142
72. Landmesser U., Bahlmann F., Mueller M., et al. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 111 (2005) 2356-2363
73. Bahlmann F.H., deGroot K.D., Mueller O., Hertel B., Haller H., and Flisser D. Stimulation of endothelial progenitor cells. A new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45 (2005) 526-529
74. Min T.Q., Zhu C.J., Xiang W.X., Hui Z.J., and Peng S.Y. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 18 (2004) 203-209
75. Strehlow K., Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065
76. Iwakura A., Luedemann C., Shastry S., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108 (2003) 3115-3121
77. Foresta C., Lana A., Cabrelle A., et al. PDE-5 inhibitor, vardenafil, increases circulating progenitor cells in humans. Int J Impot Res 17 (2005) 377-380
78. Zhu J.H., Wang X.X., Chen J.Z., et al. Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood. Acta Pharmacol Sin 25 (2004) 1045-1051
79. Chen J., Wang X., Zhu J., Shang Y., Guo X., and Sun J. Effects of Ginkgo biloba extract on number and activity of endothelial progenitor cells from peripheral blood. J Cardiovasc Pharmacol 43 (2004) 347-352
80. Butzal M., Loges S., Schweizer M., et al. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Exp Cell Res 300 (2004) 65-71
81. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiological stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
82. Bahlmann F.H., DeGroot K., Duckert T., et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 64 (2003) 1648-1652
83. Bahlmann F.H., deGroot K., Spandau J.M., et al. Erythropoietin regulates endothelial progenitor cells. Blood 103 (2004) 921-926
84. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
85. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone-marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
86. Iwaguro H., Yamaguchi J., Kalka C., et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105 (2002) 732-738
87. Zhang Z.G., Zhang L., Jiang Q., and Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90 (2002) 284-288
88. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
89. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
90. Hamano K., Nishida M., Hirata K., et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65 (2001) 845-847
91. Stamm C., Westphal B., Kleine H.-D., et al. Autologous bone marrow transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
92. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
93. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44 (2004) 1690-1699
94. Assmus B., Schachlinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
95. Britten M.B., Abolmaali N.D., Assmus B., et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108 (2003) 2212-2218
96. Wollert K.C., Meyer G.P., Latz J., et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 364 (2004) 141-148
97. Fernandez-Aviles F., San Roman J.A., Garci{dotless}a-Frade J., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95 (2004) 742-748
98. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
99. Tse H.-F., Kwong Y.-L., Chan J.K.F., Lo G., Ho C.L., and Lau C.P. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
100. Perin E.C., Dohmann H.F.R., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
101. Tateishi-Yuyama E., Matsubara H., Murohara T., et al., Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
102. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
103. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
104. Goodell M.A., Jackson K.A., Majka S.M., et al. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 938 (2001) 208-218
105. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infracted myocardium. Nature 410 (2001) 701-705
106. Li R.K., Mickle D.A., Weisel R.D., Rao V., and Jia Z.Q. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 72 (2001) 1957-1963
107. Ziegelhoeffer T., Fernandez B., Kostin S., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94 (2004) 230-238
108. Kaushal S., Amiel G.E., Guleserian K.J., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7 (2001) 1035-1040
109. Crosby J.R., Kaminski W.E., Schatteman G., et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 87 (2000) 728-730
110. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
111. Hess D.C., Hill W.D., Martin-Studdard A., Carroll J., Brailer J., and Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33 (2002) 1362-1368
112. Werner N., Junk S., Laufs U., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93 (2003) e17-e24
113. Gulati R., Jevremovic D., Peterson T.E., et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 108 (2003) 1520-1526
114. Li T.S., Hamano K., Nishida M., et al. CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 285 (2003) H931-H937
115. Kamihata H., Matsubara H., Nishiue T., et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol 22 (2002) 1804-1810
116. Gulati R., Jevremovic D., Witt T.A., et al. Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells. Am J Physiol Heart Circ Physiol 287 (2004) H512-H517
117. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2 (+)AC133 (+) endothelial precursor cells. Circ Res 88 (2001) 167-174
118. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
119. Zentilin L., Tafuro S., Zacchigna S., et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 107 (2006) 3546-3554
120. Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39 (2005) 733-742
121. Menasche P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280